SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000909661-06-000061
Filing Date
2006-12-07
Accepted
2006-12-07 17:05:51
Documents
1
Group Members
CHUN R. DINGDAVID I. COHENDEREK C. SCHRIERFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL OFFSHORE INVESTORS II, L.P.FARALLON CAPITAL PARTNERS,

Document Format Files

Seq Description Document Type Size
1 crl13g.txt SC 13G 100912
  Complete submission text file 0000909661-06-000061.txt   104426
Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279
Type: SC 13G

Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Subject) CIK: 0001100682 (see all company filings)

IRS No.: 061397316
Type: SC 13G | Act: 34 | File No.: 005-59553 | Film No.: 061263319
SIC: 2836 Biological Products, (No Diagnostic Substances)